Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
AWMSG issues Final Appraisal Report on ranolazine (Ranexa®) as add-on therapy for symptomatic treatment of stable angina pectoris

Source: All Wales Medicines Strategy Group (AWMSG)

Date published: 04/02/2010 16:25

Summary
by: Anonymous

In its Final Appraisal Report, the All Wales Medicines Strategy Group (AWMSG) does not recommend the use of ranolazine (Ranexa®) within NHS Wales for the treatment of stable angina pectoris as the case for cost effectiveness had not been proven.

Link (Ranolazine)

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Back